ÂÜÀòÂÒÂ×

Ken is an executive and biomedical scientist with 25 years of experience in the biotechnology and biopharmaceutical industries. Previously he was President & CEO of iTP Biomedica (an innovative diagnostics company), Vice President, Scientific & Regulatory Affairs at Innovative Medicines Canada (the Industry Association for Canada’s Research-Based Pharmaceutical Companies, formerly know as Rx&D) and Co-founder and Advisory Board member of the innovative biotechnology company PlantForm Corporation. He is also the founder and President of Roker Biotechnologies Inc., a company that provides consulting services to the Biotechnology and Biopharmaceutical industries. Ken received his PhD from the University of London (UK) and until 2010 served as Vice President, Scientific Affairs at Microbix.